MIPS/MACRA Quality Reporting for Anesthesia Groups: What's Changing and How to Simplify It
Anesthesia groups face a quality reporting requirement that most other specialties don't have to think as hard about: a patient-reported experience survey. It's a small piece of a much larger program, but it's often the piece that creates the most administrative friction — a separate vendor, a separate contract, and a separate data stream to reconcile against everything else in the revenue cycle. Here's what the requirement actually involves, what's changing heading into 2027, and how anesthesia groups can simplify it.
A Quick Refresher on MACRA and MIPS
The Merit-based Incentive Payment System (MIPS) — created under MACRA — adjusts Medicare reimbursement up or down based on a clinician's or group's performance across several categories, with Quality carrying significant weight in the overall score. MIPS-eligible clinicians and groups must report on six quality measures for the full performance year, and at least one of those measures must be an outcome measure (or a high-priority measure if no applicable outcome measure exists).
Why Anesthesia Groups Lean on Patient Experience Surveys
True outcome measures are hard to come by in anesthesia. Because of that, most anesthesia groups satisfy the outcome-measure requirement using AQI48 — Patient-Reported Experience with Anesthesia — a measure built on a short patient survey administered after the procedure, capturing feedback on communication, comfort, and overall experience.
Historically, collecting this data has meant contracting with a dedicated survey vendor — companies like SurveyVitals or Provation's Patient Experience Survey module (part of their Quality Concierge platform) — that administers the survey, aggregates responses, and packages the data for submission through a Qualified Clinical Data Registry (QCDR). It works, but it also means anesthesia groups often end up managing yet another vendor relationship, contract, and invoice on top of their billing and credentialing partners.
What's Changing for 2027
CMS's proposed CY 2027 Physician Fee Schedule rule, released in July 2026, includes several changes that directly affect how anesthesia groups will approach quality reporting going forward:
The anesthesiology specialty measure set is shifting. The proposed rule would retire the PONV/POV combination-therapy measures (Q430 and Q463) and add two new measures to the anesthesiology set: Patient-Reported Experience with Anesthesia and Intraoperative Hypotension Among Non-Emergent Noncardiac Surgical Cases.
Some measures that previously required a QCDR relationship are being opened up. Under the proposed rule, several measures that could formerly only be reported through a QCDR would become available through any qualified registry — reducing the need for a narrow, specialty-specific vendor relationship just to report a single measure.
Traditional MIPS has a proposed expiration date. CMS has proposed sunsetting the traditional MIPS reporting option after the CY 2028 performance period, with MIPS Value Pathways (MVPs) becoming the only reporting option starting with the CY 2029 performance year. Groups still reporting under traditional MIPS have a limited runway to plan their transition.
These are proposed changes, not final — CMS typically finalizes Physician Fee Schedule rules in the fall for the following performance year, so anesthesia groups should watch for the final rule before making reporting decisions, but should start planning now regardless of the exact final details.
Why This Is a Good Moment to Rethink Your Reporting Setup
As quality measure reporting becomes less tied to single-purpose QCDR vendor relationships, anesthesia groups have a real opportunity to consolidate. There's no inherent reason patient experience survey administration, quality measure reporting, and revenue cycle management need to live with three different vendors — especially when the underlying data (case volume, provider rosters, patient encounters) already flows through your RCM partner as part of normal billing operations.
A full-service RCM partner that also handles quality reporting can offer some real practical advantages:
One point of accountability instead of coordinating between a billing company, a credentialing vendor, and a separate survey/QCDR vendor
Better data alignment, since the same underlying case and encounter data used for billing can support quality measure reporting without duplicate data entry
Simpler renewals, with one contract and one relationship to manage instead of several
Faster adaptation to regulatory changes, since a partner already embedded in your billing operations can adjust measure selection and reporting workflows without a separate vendor's timeline
What Anesthesia Groups Should Do Now
Review your current measure selection against the proposed CY 2027 anesthesiology measure set changes, and flag anything that may need to shift.
Check your current survey vendor contract for auto-renewal terms and notice periods, so you're not locked in if you want to consolidate.
Ask whether your RCM partner can absorb quality reporting. If they can't today, it's worth asking what their roadmap looks like — this is becoming more feasible as CMS reduces the QCDR-exclusivity of certain measures.
Start planning your MVP transition now, even though traditional MIPS is still available through CY 2028. The groups that wait until the final performance year tend to scramble.
Final Thoughts
Quality reporting for anesthesia groups has long meant juggling an extra vendor just to satisfy one outcome measure. As CMS gradually loosens the QCDR-exclusivity requirements on certain measures, that no longer has to be the case. Groups that consolidate quality reporting with their RCM partner now will be better positioned for the MVP transition — and will have one fewer vendor relationship to manage along the way.
Ebility.io provides full-service RCM for anesthesiology groups — including MIPS/MACRA quality reporting alongside billing, credentialing, and contract negotiation, all under one roof. Learn more about our services.